Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InnovAge Holding Corp. (INNV : NSDQ)

• Company Description    InnovAge Holding Corp. is a healthcare delivery platform. The Company delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors as well as it serve participants primarily through Program of All-inclusive Care for the Elderly. InnovAge Holding Corp. is based in DENVER, United States. Number of Employees: 2,350

• Price / Volume Information    Yesterday's Closing Price: $4.62 Daily Weekly Monthly 20 Day Moving Average: 25,451 shares Shares Outstanding: 135.64 (millions) Market Capitalization: $626.65 (millions) Beta: 0.52 52 Week High: $6.69 52 Week Low: $2.60 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 30.88% 28.51% 12 Week 21.90% 10.68% Year To Date 17.56% 4.96%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8950 E. LOWRY BOULEVARD - DENVER,CO 80230 USA ph: 844-803-8745 fax: - rkubota@innovage.com http://www.innovage.com

• General Corporate Information    Officers Patrick Blair - Chief Executive Officer James Carlson - Chairman of the Board Benjamin C. Adams - Chief Financial Officer John Ellis Bush - Director Andrew Cavanna - Director Peer Information InnovAge Holding Corp. (CHCR) InnovAge Holding Corp. (ESRX) InnovAge Holding Corp. (MYDP) InnovAge Holding Corp. (COR) InnovAge Holding Corp. (GBCS) InnovAge Holding Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45784A104 SIC: 8000 Fiscal Year Fiscal Year End: June Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 135.64 Most Recent Split Date: (:1) Beta: 0.52 Market Capitalization: $626.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: 92.40 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.62 Price/Cash Flow: - Price / Sales: 0.73 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: 87.50% Sales Growth vs. Year Ago Period: 11.04% vs. Previous Quarter: 1.50% ROE 06/30/25 - -12.02 03/31/25 - -11.91 12/31/24 - -9.45 ROA 06/30/25 - -5.73 03/31/25 - -5.85 12/31/24 - -4.84 Current Ratio 06/30/25 - 1.07 03/31/25 - 0.78 12/31/24 - 1.16 Quick Ratio 06/30/25 - - 03/31/25 - 0.78 12/31/24 - 1.16 Operating Margin 06/30/25 - -3.55 03/31/25 - -3.75 12/31/24 - -3.19 Net Margin 06/30/25 - -3.55 03/31/25 - -3.75 12/31/24 - -3.19 Pre-Tax Margin 06/30/25 - -3.99 03/31/25 - -3.70 12/31/24 - -3.24 Book Value 06/30/25 - - 03/31/25 - 1.82 12/31/24 - 1.89 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.27 03/31/25 - 0.04 12/31/24 - 0.27 Debt-to-Capital 06/30/25 - 27.45 03/31/25 - 11.74 12/31/24 - 26.07

Powered by Zacks Investment Research ©